These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17973316)

  • 41. Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood.
    Mussolin L; Pillon M; Conter V; Piglione M; Lo Nigro L; Pierani P; Micalizzi C; Buffardi S; Basso G; Zanesco L; Rosolen A
    J Clin Oncol; 2007 Nov; 25(33):5254-61. PubMed ID: 18024872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute lymphoblastic leukemia.
    Onciu M
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):655-74. PubMed ID: 19577163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring minimal residual disease in pediatric hematologic malignancies.
    Campana D
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):876-7, 915. PubMed ID: 18185484
    [No Abstract]   [Full Text] [Related]  

  • 44. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
    Leonard JP; Gregory SA; Maloney DG; Vose JM; Younes A; Zelenetz AD
    Clin Adv Hematol Oncol; 2008 Jun; 6(6):437-45. PubMed ID: 18567989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence.
    Attias D; Weitzman S
    Curr Opin Pediatr; 2008 Feb; 20(1):17-22. PubMed ID: 18197034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.
    Martín A; Conde E; Arnan M; Canales MA; Deben G; Sancho JM; Andreu R; Salar A; García-Sanchez P; Vázquez L; Nistal S; Requena MJ; Donato EM; González JA; León A; Ruiz C; Grande C; González-Barca E; Caballero MD;
    Haematologica; 2008 Dec; 93(12):1829-36. PubMed ID: 18945747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Late relapse in a case of childhood acute lymphoblastic leukemia.
    Lodha R; Jain Y; Pemde H; Bhargava M; Arya LS
    Indian Pediatr; 1998 Mar; 35(3):281-3. PubMed ID: 9707888
    [No Abstract]   [Full Text] [Related]  

  • 49. Infant acute bilineal leukemia.
    Derwich K; Sedek L; Meyer C; Pieczonka A; Dawidowska M; Gaworczyk A; Wachowiak J; Konatkowska B; Witt M; Marschalek R; Szczepański T
    Leuk Res; 2009 Jul; 33(7):1005-8. PubMed ID: 19286255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Childhood T-cell acute lymphoblastic leukemia with four distinct immunophenotypes representing different stages of T-cell development.
    Miura T; Ouhira M; Koseki N; Obara Y; Fujimaki S; Imaizumi M; Kameoka J; Sasaki T; Funato T; Harigae H; Kaku M
    Pediatr Hematol Oncol; 2001 Jun; 18(4):267-72. PubMed ID: 11400651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Rituximab resistance in B-cell lymphoma and its elimination].
    Hatake K; Terui Y
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):548-51. PubMed ID: 19381025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pre-transplant minimal residual disease in children with acute lymphoblastic leukemia.
    Mehta PA; Davies SM
    Pediatr Blood Cancer; 2007 Jan; 48(1):1-2. PubMed ID: 16642487
    [No Abstract]   [Full Text] [Related]  

  • 54. Methodological approach to minimal residual disease detection by flow cytometry in adult B-lineage acute lymphoblastic leukemia.
    Krampera M; Perbellini O; Vincenzi C; Zampieri F; Pasini A; Scupoli MT; Guarini A; De Propris MS; Coustan-Smith E; Campana D; Foà R; Pizzolo G
    Haematologica; 2006 Aug; 91(8):1109-12. PubMed ID: 16885052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
    Reman O; Pigneux A; Huguet F; Vey N; Delannoy A; Fegueux N; de Botton S; Stamatoullas A; Tournilhac O; Buzyn A; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant JP; Fière D; Dombret H; Thomas X;
    Leuk Res; 2008 Nov; 32(11):1741-50. PubMed ID: 18508120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Risk-adapted therapeutic stratification of infantile acute lymphocytic leukemia based on MLL-gene rearrangement].
    Tomizawa D
    Rinsho Ketsueki; 2008 Mar; 49(3):171-81. PubMed ID: 18421958
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment strategy for adult acute lymphoblastic leukemia].
    Okamoto S
    Rinsho Ketsueki; 2002 Jun; 43(6):427-32. PubMed ID: 12134694
    [No Abstract]   [Full Text] [Related]  

  • 58. [Minimal residual disease in childhood acute leukemias].
    Pawińska K; Balwierz W; Baran J
    Przegl Lek; 2006; 63(1):41-3. PubMed ID: 16892899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin.
    Gobbi G; Mirandola P; Malinverno C; Sponzilli I; Carubbi C; Ricci F; Binazzi R; Basso G; Giuliani-Piccari G; Ramazzotti G; Pasquantonio G; Cocco L; Vitale M
    Int J Oncol; 2008 Aug; 33(2):371-4. PubMed ID: 18636158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Significance of four MRD markers in MRD-based treatment strategy for childhood acute lymphoblastic leukemia.
    Sawada A; Sakata N; Kishimoto T; Higuchi B; Koyama M; Kondo O; Sato E; Okamura T; Yasui M; Inoue M; Yoshioka A; Kawa K
    Leuk Res; 2009 Dec; 33(12):1710-3. PubMed ID: 19596431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.